Nath Bio-Genes (India) Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on August 22, 2025
NATHBIOGEN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Nath Bio-Genes has informed the exchanges about its 32nd Annual General Meeting scheduled for Friday, August 22, 2025 at 11:00 a.m., to be held through video conferencing. Shareholders will consider adoption of the audited standalone and consolidated financial statements for FY 2024-25, and approve a final dividend of ₹2 per equity share (face value ₹10), which is a 20% payout subject to shareholder approval. The agenda also includes the re-appointment of Mrs. Jeevanlata Kagliwal as Director (retiring by rotation), appointment of Ms. Neha P Agrawal as Secretarial Auditor for five years (FY 2025-26 to FY 2029-30), appointment of Ms. Payal Jain as Independent Director, and re-appointment of Mr. Vadla Nagabhushanam and Mr. Madhukar Deshpande as Independent Directors. Remote e-voting will be open from August 19, 2025 (9:00 a.m.) to August 21, 2025 (5:00 p.m.) via NSDL, with the cut-off and record date set as August 14, 2025.
Eligible shareholders on the record date of August 14, 2025 can vote electronically on the resolutions and stand to receive a ₹2 per share dividend from August 29, 2025 if approved at the AGM. The outcome of the meeting and any new information shared during the management discussion could influence short-term sentiment in the stock.